A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
for Migraine
114 locations incl. Birmingham
Sponsor: Kallyope Inc.
Sex: All·Age: 18 - 75
Code: NCT07645924·Phase 3·Recruiting·Listed Jun 12, 2026
Clinical research site in Chicago, Illinois · 800 S WELLS ST STE M15, CHICAGO, IL 60607-4559 · (312) 431-6780 · Website
As of July 2026, 7 paid clinical trials are recruiting at Cedar Crosse Research Center in Chicago, Illinois. Active studies at this site cover conditions such as Migraine, Obesity and Type 2 Diabetes. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Paid clinical trials in Chicago, IL · Illinois clinical trials